walmart pharmacy glp-1 revenue
Walmart's Silent Nutrition Weight Loss Bet Exposed
Walmart is turning GLP-1 drugs into a revenue growth engine, shifting its pharmacy model from a cost center to a profit driver. In its Q4 earnings call, executives highlighted a "mix shift" that could reshape earnings through 2026, signaling a strategic pivot for the retailer’s health segment.